Rhabdomyolysis following Cardiac Surgery: A Prospective, Descriptive, Single-Center Study

Table 1

Clinical variables in both groups.

Variable	Group I; (RML)	Group II; (no RML)	value
Age	47 ± 11	52 ± 11	0.08
Sex male	16 (94.1%)	169 (91.8%)	0.74
Hypertension	14 (82.5%)	123 (66.8%)	0.15
IDDM	0	16	0.28
NIDDM	4	79	0.07
BMI	28.7 ± 5.9	27.4 ± 4.8	0.4
Ethnicity (Arab)	4 (23.5%)	56 (30.4%)	0.43
ASA III	7 (41.1)	88 (47.8)	0.7
ASA IV	10 (58.8)	96 (52.1)	0.6
Euro score	3 ± 2.5	2.5 ± 2.3	0.47
Liver diseases	1 (5.8%)	2 (1%)	0.23
CRD	3 (17.6%)	18 (9.6%)	0.25
Statin usage	8 (47.1)	136 (73.5)	0.02
Inotrops
Dopamine	10 (58.8%)	47 (25.5%)	0.03
Adrenaline	3 (17.6%)	24 (13%)	0.4
Noradrenline	6 (35.3)	52 (28.4%)	0.3
Surgery
CABG	12 (70.6%)	140 (76%)	0.6
Valvular	2 (11.7%)	40 (21.7%)	0.01
Aortic dissec.	3 (17.7%)	0	0.001
Procedure type (urgent)	5 (29.4%)	41 (22.2%)	0.59
CPB time (minutes)	181.7 ± 75	110.7 ± 47	0.004
ACC time (minutes)	110.2 ± 12	68.6 ± 2.4	0.0001
Anesthesia time (min)	478.5 ± 168	362.7 ± 25	0.017
IABP	1 (5.8%)	9 (4.8%)	0.7
CHF	6 (35.3%)	66 (35%)	0.6
Complication
Arrhythmia	3 (17%)	17 (7.5%)	0.2
MI	0	9 (4.9%)	0.4
Infection	2 (11.8%)	4 (2.2%)	0.05
Early stroke	1	0

IDDM: insulin-dependant diabetes mellitus; NIDDM: non-insulin-dependent diabetes mellitus; BMI: body mass index; CBG: coronary artery bypass graft; CPB: cardiopulmonary bypass; ACC: aortic cross-clamp; IABP: intra-aortic balloon pump; CHF: congestive heart failure; MI: myocardial infarction.